Literature DB >> 9745978

Interstitial cystitis.

D R Erickson1, M F Davies.   

Abstract

Interstitial cystitis (IC) is a multifactorial syndrome with symptoms of pelvic or perineal pain, urinary frequency and urgency. The etiologies are unknown, but several theories have been proposed. Diagnosis is often delayed because most of the conventional evaluation is normal. Pelvic examination is normal except for bladder tenderness. Urodynamics are normal except for increased bladder sensitivity and low capacity. Urinalysis, urine culture and office cystoscopy are also normal. The diagnostic test is cystoscopy under anesthesia with bladder distension. Small submucosal hemorrhages (glomerulations) or ulcers appear after distension. Many empiric treatments have been proposed for IC. None is universally effective, and so treatments are tried sequentially until good symptom relief is achieved. Bladder distension gives excellent (but transient) relief in some patients, especially those with severe bladder inflammation (who also tend to be older). A variety of oral, intravesical and adjunctive treatments are also described.

Entities:  

Mesh:

Year:  1998        PMID: 9745978     DOI: 10.1007/bf02001088

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  91 in total

1.  Pelvic pain without pelvic organs.

Authors:  L S Baskin; E A Tanagho
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

Review 2.  1994 ASRA Lecture. The pathogenesis of neuropathic pain.

Authors:  R R Myers
Journal:  Reg Anesth       Date:  1995 May-Jun

3.  Stress-induced bladder mast cell activation: implications for interstitial cystitis.

Authors:  C Spanos; X Pang; K Ligris; R Letourneau; L Alferes; N Alexacos; G R Sant; T C Theoharides
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

4.  Urodynamic studies in interstitial cystitis.

Authors:  R Perez-Marrero; L Emerson; S Juma
Journal:  Urology       Date:  1987-04       Impact factor: 2.649

5.  Vascular immunopathology in interstitial cystitis.

Authors:  J Mattila
Journal:  Clin Immunol Immunopathol       Date:  1982-06

Review 6.  Interstitial cystitis as an autoimmune disease. A review.

Authors:  K J Oravisto
Journal:  Eur Urol       Date:  1980       Impact factor: 20.096

7.  Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.

Authors:  D R Erickson; S Ordille; A Martin; V P Bhavanandan
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

8.  A prospective study of microorganisms in urine and bladder biopsies from interstitial cystitis patients and controls.

Authors:  S Keay; R S Schwalbe; A L Trifillis; J C Lovchik; S Jacobs; J W Warren
Journal:  Urology       Date:  1995-02       Impact factor: 2.649

9.  Clinical and immunological response to nifedipine for the treatment of interstitial cystitis.

Authors:  J D Fleischmann; H N Huntley; W B Shingleton; D B Wentworth
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

Review 10.  Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis.

Authors:  M Fall; S Lindström
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

View more
  5 in total

1.  Complementary and alternative therapies as treatment approaches for interstitial cystitis.

Authors:  Kristene E Whitmore
Journal:  Rev Urol       Date:  2002

2.  Role for pituitary adenylate cyclase activating polypeptide in cystitis-induced plasticity of micturition reflexes.

Authors:  Karen M Braas; Victor May; Peter Zvara; Bernhard Nausch; Jan Kliment; J Dana Dunleavy; Mark T Nelson; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-12-01       Impact factor: 3.619

3.  PACAP-mediated ATP release from rat urothelium and regulation of PACAP/VIP and receptor mRNA in micturition pathways after cyclophosphamide (CYP)-induced cystitis.

Authors:  Beatrice M Girard; Amanda Wolf-Johnston; Karen M Braas; Lori A Birder; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2008-06-19       Impact factor: 3.444

4.  Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells.

Authors:  Zun-Yi Wang; Peiqing Wang; Dale E Bjorling
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-12       Impact factor: 3.619

5.  Activation of cannabinoid receptor 2 inhibits experimental cystitis.

Authors:  Zun-Yi Wang; Peiqing Wang; Dale E Bjorling
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-20       Impact factor: 3.619

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.